Oncologic progression of bone plasmacytomas to multiple myeloma

Clinics

Volumn 61, Issue 2, 2006, Pages 139-146

  Bertanha, Fernanda ^a   Boufelli, Gabriela ^a   De Camargo, Olavo Pires ^a   Baptista, André Mathias ^a   Caiero, Marcelo Tadeu ^a   De Oliveira, Claudia Regina G C M ^a   Filippi, Renée ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Clinical progression; Multiple myeloma; Plasma cells; Plasmacytoma; Prognosis

Indexed keywords

EID: 33646410444     PISSN: 18075932     EISSN: None     Source Type: Journal    
DOI: 10.1590/S1807-59322006000200009     Document Type: Article

References (31)

1. MacIntyre W. Case of mollities and fragilitas ossium accompanied with urine strongly charged with animal matter. Med Chir Soc Tr. 1850;33:211.
2. Rustizky J. Multiple myeloma. Deutsche Ztschr F. Chir. 1873;3:162.
3. Kahler O. Zur Symptomatologie des multiplen Myeloms: Beobachtung von Albumosurie. Prog Med Wochnschr. 1889;14:33:45.
4. Potter M. Perspectives on the origins of multiple myeloma and plasmacytomas in mice. Hematol Oncol Clin North Am. 6:211-23.
5. Waldenstrom J. Diagnosis and treatment of multiple myeloma. New York: Editorial Médica; 1973.
6. Riedel DA, Pottern LM. The epidemiology of multiple myeloma. Hematol Oncol Clin North Am. 6:225-47.
7. Coskun HS, Er O, Soyuer S, Altinbas M, Eser B, Karahacioglu E, , et al. Solitary plasmacytoma: experiences from Central Anatolia. Ir J Med Sci. 2005;174:33-6.
8. Blattner WA, Blair A, Maron TJ. Multiple myeloma in the United States 1950-1975. Cancer. 1981;48:2547.
9. Fassas A, Tricot G. Results of high-dose treatment with autologous stem cell support in patients with multiple myeloma. Semin Hematol. 2001;38:231-42.
10. Durie BG, Salmon SE. A clinical staging system for multiple myeloma. Correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival. Cancer. 1975;36:842-54.
11. Dimopoulos MA, Moulopoulos A, Delasalle K, Alexanian R. Solitary plasmacytoma of bone and asymptomatic multiple myeloma. Hematol Oncol Clin North Am. 1992;6:359-69.
12. Olmo JA Del. Osteopatías hematológicas. In: Querol JR. Patología Ósea. Barcelona: Ed. Espaxs Publicaciones Médicas; 1983. p. 376-82.
13. Bataille R, Sany J. Solitary myeloma: clinical and prognostic features of a review of 114 cases. Cancer. 1981;48:845-51.
14. Quintero M, Rojas-Atencio A, Ruiz A, Gonzalez M, Herrera J, Atencio F, et al. Chromosome anomalies in Venezuelan patients with multiple myeloma. Invest Clin. 2003;44:327-35.
15. Di Micco P, Di Micco B. Update on solitary plasmacytoma and its main differences with multiple myeloma. Exp Oncol. 2005;27:7-12.
16. Holland J, Trenkner DA, Wasserman TH, Fineberg B. Plasmacytoma, treatment results and conversion to myeloma. Cancer. 1992;69:1513-7.
17. Kumar A, Loughran T, Alsina M, Durie BG, Djulbegovic B. Management of multiple myeloma: a systematic review and critical appraisal of published studies. Lancet Oncol. 2003;4:293-304.
18. nd. ed. Rio de Janeiro: Ed. Revinter; 2000.
19. Sonneveld P, Segeren CM. Changing concepts in multiple myeloma: from conventional chemotherapy to high-dose treatment. Eur J Cancer. 2003;39:9-18.
20. Yan TQ, Guo W, Tang XD, Tang S. Clinical study of solitary bone plasmacytoma. Zhonghua Wai Ke Za Zhi. 2003;41:749-52.
21. Kaplan EI, Meier P. Non- parametric estimation from incomplete observations. J Am Stat Assoc. 1958;53:457.
22. Bataille R, Donadio D, Morlock G, Rosenberg F, Blotman F, Sany J et al. Multiple myeloma of bones. Retrospective study of prognostic factors based on a series of 243 patients. Rev Rhum Mal Osteoartic. 1979;46:77-83.
23. Bataille R, Morlock G, Rosenberg F, Lopitaux R, Blotman F, Sany J, et al. [Value of successive chemotherapy in multiple myeloma of bone. Prospective study over 4 years]. Rev Rhum Mal Osteoartic. 1980;47:77-82. (French)
24. Durie BG, Salmon SE. Multiple myeloma, macroglobulinaemia and monoclonal gammopathies. In: Hoffbrand AV, Brain MC, Hirsh J, editors. Recent Advances in Haematology. Edinburgh: Churchill Livingstone; 1977. p. 243-60.
25. Knowling MA, Harwood AR, Bergsagel DF. Comparison of extramedullary plasmacytoma with solitary and multiple plasma cell tumors of bone. J Clin Oncol. 1983;1:255-62.
26. Chak L, Cax RS, Bostwick DG, Hoppe RT. Solitary plasmacytoma of bone: treatment, progression, and survival. J Clin Oncol. 1987;5:1811-5.
27. Frassica DA, Frassica FJ, Shray MF, Sim FH, Kyle RA. Solitary plasmacytoma of bone. Int J Radiat Oncol Biol Phys. 1989;16:43-8.
28. Mayr NA, Wen BC, Hussey DH, Burns CP, Staples JJ, Doornbos JF, et al. The role of radiation therapy in the treatment of solitary plasmacytomas. Radiother Oncol. 1990;17:292.
29. Etchebehere M, Camargo OP, Croci AT Oliveira CRCM, Batista AM. Relationship between surgical procedure and outcome for patients with grade I chondrosarcomas. Clinics. 2005;60:121-126.
30. Camargo OP de, Croci AT, Oliveira CRGMC de, Baptista AM, Caiero MT. Functional and radiographic evaluation of 214 aggressive benign bone lesions treated with curettage, cauterization, and cementation: 24 years of follow-up. Clinics. 2005;60:439-444.
31. Vaz CES, Camargo OP de, Santana PJ de, Valezi AC. Accuracy of magnetic resonance in identifying traumatic intraarticular knee lesions. Clinics. 2005;60:445-450.